🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

30 results for “Gilead Sciences International Limited” Clear

  1. Trodelvy 200 mg powder for concentrate for solution for infusion

    Gilead Sciences International Limited

    Metastatic Solid Tumors

    phase 2 small molecule active

    1 trial

  2. Trodelvy 200 mg powder for concentrate for solution for infusion, Carboplatin 10 mg/ml Concentrate for Solution for Infusion, Cisplatin 1 mg/ml Concentrate for Solution for Infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion

    Gilead Sciences International Limited

    Non-small cell lung cancer

    phase 2 small molecule active

    1 trial

  3. GS-5245 tablets 175 mg, GS-5245 tablets 350 mg

    Gilead Sciences International Limited

    Renal Impairment

    phase 1 small molecule active

    1 trial

  4. Study of GS-0151 in Participants With Rheumatoid Arthritis

    Gilead Sciences International Limited

    Rheumatoid Arthritis

    phase 1 other active

    1 trial

  5. Study of GS-5319 in Adults With Solid Tumors

    Gilead Sciences International Limited

    Advanced solid tumors

    phase 1 other active

    1 trial

  6. Biktarvy 50 mg/200 mg/25 mg film-coated tablets

    Gilead Sciences International Limited

    HIV-1 infection

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources